While we wait
This scenario may come up the stage, if clinical trials are completed by December or January, and a company would file an application, which means there will be an approved vaccine by next summer, FDA Director General Eric Domingo, replying to a question, said in a virtual press briefing on Friday. This best-case scenario of between three and six months will allow those deeply involved in the vaccine to complete all their analyses which they will submit to the authorities posthaste. This time frame is the experts’ estimate on Phase III clinical trials of COVID-19 vaccines, Science Secretary Fortunato de la Peña explained in the same briefing. The experts prefer to use the longer forecast in their estimate, since that would indicate that in that period they would have finished the clinical trials and probably already submitted to FDA the application and the results of their trial. At the moment, the Philippines, which logged as at weekend more than 300,000 infections and more than 5,200 deaths from the coronavirus, is negotiating with 17 vaccine developers, with at least six of them having signed confidentiality disclosure agreements that would allow the sharing of their earlier trial results. The Philippine government said it would prioritize the World Health Organization’s Solidarity Trial, which involves synchronic testing of several vaccines in different countries. The WHO is scheduled to release its list of vaccines and protocols in October, which means it could only start recruiting patients by then.